Boston Medical Center joins Aspen Institute initiative for families’ economic health

BOSTON, MA – Boston Medical Center’s StreetCred program has been named to the second cohort of the Aspen Family Prosperity Innovation Community, an Aspen Institute initiative for breakthrough innovations and collaborations that position families to reach educational success, economic prosperity, and health and well-being. The launch of this community, Ascend, could not come at a…

Details

A safer cell therapy harnesses patient T cells to fight multiple myeloma

A treatment for multiple myeloma that harnesses the body’s cancer-fighting T cells was safe in humans and showed preliminary signs of effectiveness, according to a clinical trial involving 23 patients with relapsed or treatment-resistant disease. Although more research is needed to determine how well the treatment works, the trial results indicate that the regimen may…

Details

Young innovative scientists receive Damon Runyon-Sohn Pediatric Cancer Research awards

The Damon Runyon Cancer Research Foundation has named two outstanding young scientists as recipients of the Damon Runyon-Sohn Pediatric Cancer Fellowship Award, committing nearly $500,000 to help address a critical shortage of funding for pediatric cancer research. The Fellowship Award provides funding to basic scientists and clinicians who conduct research with the potential to significantly…

Details

Pimavanserin reduced symptoms of dementia-related psychosis in phase 3 trial

A large-scale trial has found a treatment with pimavanserin substantially reduced psychotic symptoms and reduced risk of relapse of those symptoms compared to placebo in people with dementia, a condition for which no treatments are currently licensed. New data presented at the Alzheimer’s Association International Conference indicates that pimavanserin leads to a robust reduction…

Details